117 related articles for article (PubMed ID: 6123540)
21. Thyrotropin binding and long acting thyroid stimulator absorbing activities in subcellular fractions from isolated thyroid cells and thyroid homogenates.
Mehdi SQ; Badger J; Kriss JP
Endocrinology; 1977 Jul; 101(1):59-65. PubMed ID: 193685
[TBL] [Abstract][Full Text] [Related]
22. Studies on the cyclic AMP response to thyroid stimulating immunoglobulin (TSI) and thyrotropin (TSH) in human thyroid cell monolayers.
Rapoport B; Filetti S; Takai N; Seto P; Halverson G
Metabolism; 1982 Nov; 31(11):1159-67. PubMed ID: 6127595
[TBL] [Abstract][Full Text] [Related]
23. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
Noh J; Hamada N; Saito H; Oyanagi H; Ishikawa N; Momotani N; Ito K; Morii H
J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
[TBL] [Abstract][Full Text] [Related]
24. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
Shinozawa T; Villadolid MC; Ingbar SH
J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
[TBL] [Abstract][Full Text] [Related]
25. The thyrotrophin receptor in human thyroid plasma membranes: effect of serum immunoglobulins.
Bryson JM; Joasoo A; Turtle JR
Acta Endocrinol (Copenh); 1976 Nov; 83(3):528-38. PubMed ID: 62481
[TBL] [Abstract][Full Text] [Related]
26. Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.
Yamashita K; Field JB
J Clin Invest; 1972 Mar; 51(3):463-72. PubMed ID: 4110896
[TBL] [Abstract][Full Text] [Related]
27. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
[TBL] [Abstract][Full Text] [Related]
28. Photoaffinity labelling of the porcine thyrotropin receptor--effect of Graves' immunoglobulin G and anti-TSH anti-idiotypic antibodies.
Bakó G; Islam MN; Farid NR
Clin Invest Med; 1985; 8(2):152-9. PubMed ID: 2870832
[TBL] [Abstract][Full Text] [Related]
29. Calmodulin purified from human and porcine thyroids inhibits thyrotropin binding to porcine thyroid cells.
Kouki T; Inui T; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A; Ozaki O; Ito K; Kurihara H
Thyroid; 1997 Dec; 7(6):943-8. PubMed ID: 9459642
[TBL] [Abstract][Full Text] [Related]
30. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes.
Kishihara M; Nakao Y; Baba Y; Matsukura S; Kuma K; Fujita T
J Clin Endocrinol Metab; 1979 Nov; 49(5):706-11. PubMed ID: 226558
[TBL] [Abstract][Full Text] [Related]
31. TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves' disease.
Macchia E; Fenzi GF; Monzani F; Bartalena L; Lippi F; Aloisio V; Cupini C; Baschieri L; Pinchera A
J Endocrinol Invest; 1983 Oct; 6(5):375-8. PubMed ID: 6141201
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
Morris JC; Hay ID; Nelson RE; Jiang NS
Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
[TBL] [Abstract][Full Text] [Related]
33. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K
J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
[TBL] [Abstract][Full Text] [Related]
34. Inhibition by certain plant extracts of the binding and adenylate cyclase stimulatory effect of bovine thyrotropin in human thyroid membranes.
Auf'mkolk M; Ingbar JC; Amir SM; Winterhoff H; Sourgens H; Hesch RD; Ingbar SH
Endocrinology; 1984 Aug; 115(2):527-34. PubMed ID: 6745167
[TBL] [Abstract][Full Text] [Related]
35. Antithyroid Drugs Inactivate TSH Binding to the TSH Receptor by their Reducing Action.
Ochi Y; Hachiya T; Koyama Y; Fukuhori N; Ashida N
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):508-512. PubMed ID: 29468987
[TBL] [Abstract][Full Text] [Related]
36. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
[TBL] [Abstract][Full Text] [Related]
37. Binding of thyrotrophin to low molecular weight fragments of human thyroid membranes.
Adlkofer F; Kotulla P; Schleusener H
Acta Endocrinol (Copenh); 1980 May; 94(1):58-63. PubMed ID: 6247874
[TBL] [Abstract][Full Text] [Related]
38. Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay.
Vitti P; Valente WA; Ambesi-Impiombato FS; Fenzi GF; Pinchera A; Kohn LD
J Endocrinol Invest; 1982; 5(3):179-82. PubMed ID: 6286749
[TBL] [Abstract][Full Text] [Related]
39. TSH binding by globulins from patients with Graves' disease.
Bíró J
Endocrinol Exp; 1981; 15(2):145-53. PubMed ID: 6114853
[TBL] [Abstract][Full Text] [Related]
40. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.
Loeffler M; Zakarija M; McKenzie JM
J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
